Resources
Registration and ordering
Alberta Precision Labs (APL) pharmacy information package and enrollment checklist
Enrollment Checklist for COVID-19 Asymptomatic Testing Program
APL Health Care Provider Information Form
APL Specimen Collection Kit Order Form
Pharmacy Asymptomatic COVID-19 Testing Program Change Request Form
In pharmacy processes
Patient Checklist - Pharmacy asymptomatic testing program
Pharmacy Asymptomatic Testing Consent Script
Targeted asymptomatic COVID-19 testing (Benefact 897)
Test requisitions
COVID-19 Test Requisition (Pharmacy – Calgary Zone)
COVID-19 Test Requisition (Pharmacy – Central Zone)
COVID-19 Test Requisition (Pharmacy – Edmonton Zone)
COVID-19 Test Requisition (Pharmacy – North Zone)
COVID-19 Test Requisition (Pharmacy – South Zone)
Paxlovid™
Reference guide for pharmacists dispensing Paxlovid™.
Paxlovid™ - Information Session for Community Pharmacy in Alberta – January 27, 2022 [Video]
FAQ
Online Pharmacy Locator Tool – Site Information
Pharmacy-based Asymptomatic COVID-19 Testing Program information
Pharmacy-based Asymptomatic COVID-19 Testing FAQ
Alberta Blue Cross claiming process (Benefact 870).
Further information on Pharmacy-based Asymptomatic COVID-19 testing program (Benefact 892)
Alberta pharmacies
Reference Guide for the 2021-22 Alberta Influenza Immunization Program
Critical Supply Product List (PDF) | (Excel)
Nutritional Product, Package Size, and UPC Listing (PDF) | (Excel)
Alberta Blue Cross Guide to Step Therapy
Alberta Blue Cross Standard Maximum Allowable Cost (MAC) Drugs and Reference Price Listing
ASEBP TARP Drugs and Reference Price Listing
ASEBP member FAQs regarding TARP policy
Alberta Health - Over 100 days’ supply authorization request form
Frequent Dispensing Policy Q&As
Maintenance Medication Program Drug Listing
Pharmacist Prescriber Special Authorization Registration Form
Healthcare Professionals Guide – May 1, 2021
Patient Information Sheet – September 29, 2021
Patient Supports – August 30, 2021
Addition of insulin aspart biosimilar – all adult patients on NovoRapid must switch by April 1, 2022 – September 29, 2021
Addition of insulin lispro biosimilar – all adult patients on Humalog must switch by February 1, 2022 – August 1, 2021
Addition of enoxaparin biosimilars – all adult patients on Lovenox must switch by January 10, 2022 – June 1, 2021
Addition of adalimumab biosimilars – all adult patients on Humira must switch by May 1, 2022 – May 1, 2021
Addition of etanercept biosimilar for the indication of plaque psoriasis – November 2, 2020
Physician reminder biosimilars initiative – October 7, 2020
Addition of rituximab and pegfilgrastim biosimilars – September 1, 2020
New information – switch deadline extended to January 15, 2021